Navigation Links
Study Unblinded: ZYTIGA® (abiraterone acetate) Plus Prednisone for Asymptomatic or Mildly Symptomatic Chemotherapy-Naive Patients with Metastatic Castration-Resistant Prostate Cancer
Date:3/8/2012

nical symptoms or signs suggestive of hepatotoxicity develop. Elevations of AST, ALT, or bilirubin from the patient's baseline should prompt more frequent monitoring. If at any time AST or ALT rise above five times the upper limit of normal (ULN) or the bilirubin rises above three times the ULN, interrupt ZYTIGA® treatment and closely monitor liver function.

Food Effect - ZYTIGA® must be taken on an empty stomach. Exposure of abiraterone increases up to 10-fold when abiraterone acetate is taken with meals. No food should be eaten for at least two hours before the dose of ZYTIGA® is taken and for at least one hour after the dose of ZYTIGA® is taken. Abiraterone Cmax and AUC0-infinity (exposure) were increased up to 17- and 10-fold higher, respectively, when a single dose of abiraterone acetate was administered with a meal compared to a fasted state.

Adverse Reactions - The most common adverse reactions (greater than or equal to 5%) are joint swelling or discomfort, hypokalemia, edema, muscle discomfort, hot flush, diarrhea, urinary tract infection, cough, hypertension, arrhythmia, urinary frequency, nocturia, dyspepsia, fractures and upper respiratory tract infection.

Drug Interactions - ZYTIGA® is an inhibitor of the hepatic drug-metabolizing enzyme CYP2D6. Avoid coadministration with CYP2D6 substrates that have a narrow therapeutic index. If an alternative cannot be used, exercise caution and consider a dose reduction of the CYP2D6 substrate. Additionally, abiraterone is a substrate of CYP3A4 in vitro. Strong inhibitors and inducers of CYP3A4 should be avoided or used with caution.

Use in Specific Populations - The safety of ZYTIGA® in patients with baseline severe hepatic impairment has not been studied. These patients should not receive ZYTIGA®.

About Janssen Research & Development, LLC

Janssen Research & Development, LLC is headquartere
'/>"/>

SOURCE Janssen Research & Development, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... 2014  The National Association of Drug Diversion ... by the real-time, pseudoephedrine (PSE) blocking system in ... Exchange (NPLEx), automatically blocks unlawful PSE sales and ... and make arrests. Data released by NPLEx shows ... blocked the sale of more than 23,478 boxes of ...
(Date:8/20/2014)... 2014  The National Association of Drug Diversion ... by the real-time, pseudoephedrine (PSE) blocking system in ... Exchange (NPLEx), automatically blocks unlawful pseudoephedrine sales and ... and make arrests. Data released by NPLEx shows ... blocked the sale of more than 32,890 boxes of ...
(Date:8/20/2014)... , Aug. 20, 2014 Reportlinker.com ... available in its catalogue: The Impact ... Industry http://www.reportlinker.com/p01618927/The-Impact-of-Healthcare-Reform-PPACA-On-the-US-IVD-Industry.html ... (H.R. 3590) is complex legislation that affects virtually ... its provisions are beginning to take effect now. ...
Breaking Medicine Technology:Kentucky's Stop-Sale System Achieves Significant Results In Battle Against Meth 2Michigan's Stop-Sale System Achieves Significant Results In Battle Against Meth 2The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 2The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 3The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 4The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 5The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 6
... Pa., May 17, 2011 Inovio Pharmaceuticals, Inc. (NYSE ... development of therapeutic and preventive vaccines against cancers and ... its DNA vaccines and electroporation delivery technology at the ... & Cell Therapy to be held May 18-21 in ...
... May 16, 2011 Awarepoint Corporation , the ... for hospitals, announced today that it named Ralph Keiser ... as executive vice president of marketing and business development ... opportunities in the domestic and international RTLS markets. ...
Cached Medicine Technology:Inovio Pharmaceuticals to Present at American Society of Gene & Cell Therapy Annual Meeting May 18 - 21, 2011 2Inovio Pharmaceuticals to Present at American Society of Gene & Cell Therapy Annual Meeting May 18 - 21, 2011 3Inovio Pharmaceuticals to Present at American Society of Gene & Cell Therapy Annual Meeting May 18 - 21, 2011 4Awarepoint Expands Senior Management Team 2Awarepoint Expands Senior Management Team 3
(Date:8/20/2014)... Aug. 20, 2014 (HealthDay News) -- Loss of brain ... explain why many seniors have trouble falling and staying ... sleep disruption can be especially severe and often results ... The investigators analyzed data from the Rush Memory ... enrolled at age 65 and are being followed until ...
(Date:8/20/2014)... Steven Reinberg HealthDay Reporter ... speed at which cancer cells grow may help doctors diagnose ... Using this measure, investigators have found that the deadliest skin ... older men with a long history of sun exposure. ... researchers discovered. Rapid cell growth -- called "high ...
(Date:8/20/2014)... 2014 The Board of Directors of ... is pleased to announce the expansion of its ... China and the surrounding region. In support of ... AIA has relocated to the firm’s office in ... planning and design and to better support regional clients. ...
(Date:8/20/2014)... is one of the most persistent and deadliest infectious ... people each year. , Scientists who study tuberculosis have ... likely spread from humans in Africa to seals and ... and transmitted it to Native people there before Europeans ... Genomes Reveal Seals as a Source of New World ...
(Date:8/20/2014)... that sprint to spawning grounds through fast-moving waters may ... British Columbia scientists. , When salmon encounter turbulent, fast-moving ... dams they must move upstream using a behaviour ... for humans. , "Days after sockeye passed through extremely ... a short distance from their spawning grounds," said Nicholas ...
Breaking Medicine News(10 mins):Health News:Seniors' Sleep Woes May Be Linked to Loss of Brain Cells 2Health News:High-Risk Melanomas Often on Head or Neck, Study Finds 2Health News:High-Risk Melanomas Often on Head or Neck, Study Finds 3Health News:Perkins Eastman Expands Presence in China 2Health News:Perkins Eastman Expands Presence in China 3Health News:New research shows seals and sea lions likely spread tuberculosis to humans 2Health News:New research shows seals and sea lions likely spread tuberculosis to humans 3Health News:Salmon forced to 'sprint' less likely to survive migration 2
... Nov. 11 Health care costs and heightened public ... That,s according to a recent MamboTrack(TM) study by ... and organic product marketing and promotions, which surveyed the organic ... get an outlook for the coming year. , Nine ...
... ... has teamed up with world renowned high altitude mountaineer and adventure athlete Will Cross to ... , ... November 11, 2009 -- Tender Corp ., a leading manufacturer of over-the-counter topical cream ...
... Security Division of EMC (NYSE: EMC ) announced ... services company, has almost quadrupled its deployment of the ... network access in order to help guarantee business continuity. ... of employees including members of upper management. It decided ...
... OrthoAccel Technologies, Inc., developers of the ... to enhance orthodontics, announced that its application to market ... Australia,s Therapeutic Goods Administration (TGA) . ... in Australia. , (Photo: http://www.newscom.com/cgi-bin/prnh/20091111/DA09142 ...
... The New York Conference on Well-Being ... bringing together an international group of leading psychiatrists, ... and the International Network of Person-Centered Medicine organized ... and health promotion in medicine and psychiatry. Participants ...
... radiology treatment that uses targeted image-guided drug delivery ... clots in the lungssaves lives and should be ... embolism, note researchers in the November Journal ... "Modern catheter-directed therapy for acute pulmonary embolism saves ...
Cached Medicine News:Health News:Natural and Organic Consumers Focus on Health and Wellness Amidst Public Health Concerns 2Health News:High Altitude Mountaineer Will Cross Joins Tender's HealthiFeet Team to Raise Awareness On Foot Care for People Battling Diabetes 2Health News:High Altitude Mountaineer Will Cross Joins Tender's HealthiFeet Team to Raise Awareness On Foot Care for People Battling Diabetes 3Health News:High Altitude Mountaineer Will Cross Joins Tender's HealthiFeet Team to Raise Awareness On Foot Care for People Battling Diabetes 4Health News:Swiss Environmental Company Taps RSA to Ensure Business Continuity in the Event of Global H1N1 Pandemic 2Health News:Swiss Environmental Company Taps RSA to Ensure Business Continuity in the Event of Global H1N1 Pandemic 3Health News:AcceleDent System From OrthoAccel Technologies, Inc. Secures Medical Device Regulatory Clearance to Market in Australia 2Health News:AcceleDent System From OrthoAccel Technologies, Inc. Secures Medical Device Regulatory Clearance to Market in Australia 3Health News:Conference of International Experts Calls for a Focus on Well-Being and The Person in Health 2Health News:Conference of International Experts Calls for a Focus on Well-Being and The Person in Health 3Health News:When seconds count: Interventional radiology treatment for pulmonary embolism saves lives 2Health News:When seconds count: Interventional radiology treatment for pulmonary embolism saves lives 3
... drying system, 220-240 V, includes Model 583 gel ... 583 gel dryer is a vacuum-based gel dryer ... cm with variable temperature control and three preprogrammed ... vacuum pump used for pulling vacuum on gel ...
... system utilizes a hot air drying device for ... to four drying frames at once. Gels are ... viewing. The assembly table is recessed to provide ... frame. This 230 V, 50 Hz system includes ...
The GelAir™ dryer is a component of the GelAir drying system. Supplied as a 115 V, 60 Hz gel drying oven....
... voltage power supply, the 105 is very simple ... switch control the output, which is variable in ... two-position switch toggles the bright LED display from ... is equipped with an over current detector for ...
Medicine Products: